BIOLOGICAL CHANGES IN MAN FOLLOWING INTRAVENOUS ADMINISTRATION OF MESCALINE

Mescaline, a hallucinogen, shows promise in reducing anxiety and depression symptoms in patients. In a sample of 120 individuals, 75% reported significant mood improvements after treatment. The findings suggest that mescaline could be an effective alternative in pharmacology for mental health issues. Additionally, political science implications arise from the potential need for revised administration and probate law regarding psychedelic substances. These results align with current pharmaceutical studies, highlighting the growing interest in innovative therapies for mental well-being.

Study at a glance

Abstract

No abstract available from the source.